Apolipoprotein E genotype and the association between C-reactive protein and postoperative delirium: Importance of gene-protein interactions.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 26 11 2019
medline: 27 11 2020
entrez: 26 11 2019
Statut: ppublish

Résumé

Apolipoprotein E (APOE) status may modify the risk of postoperative delirium conferred by inflammation. We tested whether APOE modifies the established association between C-reactive protein (CRP) and delirium incidence, severity, and duration in 553 noncardiac surgical patients aged 70 and older. High postoperative plasma CRP (≥234.12 mg/L) was defined by the highest sample-based quartile. Delirium was determined using the Confusion Assessment Method and chart review, and severity was determined by the Confusion Assessment Method-Severity score. APOE ε4 carrier prevalence was 19%, and postoperative delirium occurred in 24%. The relationship between CRP and delirium incidence, severity, and duration differed by ε4 status. Among ε4 carriers, there was a strong relationship between high CRP (vs. low CRP) and delirium incidence (relative risk [95% confidence interval], 3.0 [1.4-6.7]); however, no significant association was observed among non-ε4 carriers (relative risk [95% CI], 1.2 [0.8-1.7]). Our findings raise the possibility that APOE ε4 carrier status may modify the relationship between postoperative day 2 CRP levels and postoperative delirium.

Identifiants

pubmed: 31761478
pii: S1552-5260(19)35476-7
doi: 10.1016/j.jalz.2019.09.080
pmc: PMC7086383
mid: NIHMS1567021
doi:

Substances chimiques

Apolipoprotein E4 0
Apolipoproteins E 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

572-580

Subventions

Organisme : NIA NIH HHS
ID : R01 AG051658
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG041274
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG035075
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062421
Pays : United States
Organisme : NIA NIH HHS
ID : K07 AG041835
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG031720
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG048600
Pays : United States
Organisme : Alzheimer's Association
Pays : International
Organisme : NIA NIH HHS
ID : R03 AG061582
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG057836
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG057955
Pays : United States
Organisme : NIA NIH HHS
ID : R24 AG054259
Pays : United States

Informations de copyright

© 2019 the Alzheimer's Association.

Références

Am J Geriatr Psychiatry. 2019 Jan;27(1):1-8
pubmed: 30424994
Atherosclerosis. 2006 May;186(1):222-4
pubmed: 16445917
Am J Geriatr Psychiatry. 2009 Oct;17(10):856-62
pubmed: 19910874
Alzheimers Dement. 2018 May;14(5):590-600
pubmed: 29190460
J Am Geriatr Soc. 2011 Nov;59 Suppl 2:S241-3
pubmed: 22091567
Alzheimers Dement. 2016 Jul;12(7):766-75
pubmed: 27103261
J Clin Exp Neuropsychol. 2010 Dec;32(10):1041-9
pubmed: 20446144
J Gen Intern Med. 2016 Oct;31(10):1164-71
pubmed: 27259291
Ann Intern Med. 2014 Apr 15;160(8):526-533
pubmed: 24733193
Am J Cardiol. 2003 Aug 21;92(4B):17K-22K
pubmed: 12948872
Ann Intern Med. 1990 Dec 15;113(12):941-8
pubmed: 2240918
Can J Anaesth. 2011 Mar;58(3):246-55
pubmed: 21222188
J Am Geriatr Soc. 2015 Dec;63(12):2463-2471
pubmed: 26662213
Crit Care. 2010;14(5):R171
pubmed: 20875113
JAMA. 1994 Jan 12;271(2):134-9
pubmed: 8264068
Am J Crit Care. 2014 Jan;23(1):49-57
pubmed: 24382617
JAMA. 2010 Jul 28;304(4):443-51
pubmed: 20664045
J Am Med Dir Assoc. 2012 Nov;13(9):818.e1-10
pubmed: 22999782
N Engl J Med. 2017 Oct 12;377(15):1456-1466
pubmed: 29020579
Ann Thorac Surg. 2009 May;87(5):1469-74
pubmed: 19379886
Nat Rev Genet. 2004 Feb;5(2):101-13
pubmed: 14735121
J Theor Biol. 2007 Jan 7;244(1):96-107
pubmed: 16949103
Age Ageing. 2014 Mar;43(2):289-92
pubmed: 24305621
Sci Rep. 2018 Jul 10;8(1):10395
pubmed: 29991691
Anal Biochem. 1988 Nov 1;174(2):485-8
pubmed: 3239751
JAMA. 2012 Jul 4;308(1):73-81
pubmed: 22669559
Crit Care Med. 2007 Jan;35(1):112-7
pubmed: 17133176
Clin Endocrinol (Oxf). 2006 Mar;64(3):265-70
pubmed: 16487435
J Am Geriatr Soc. 2000 Jun;48(6):618-24
pubmed: 10855596
J Am Geriatr Soc. 2014 Mar;62(3):518-24
pubmed: 24512042
PLoS One. 2017 Mar 14;12(3):e0172268
pubmed: 28291794
Am J Geriatr Psychiatry. 2013 Oct;21(10):935-7
pubmed: 23969090
J Am Geriatr Soc. 2017 Aug;65(8):e109-e116
pubmed: 28555781
Lancet Neurol. 2015 Aug;14(8):823-832
pubmed: 26139023
JAMA Psychiatry. 2017 Mar 1;74(3):244-251
pubmed: 28114436
Brain. 2012 Sep;135(Pt 9):2809-16
pubmed: 22879644
Atherosclerosis. 2011 Nov;219(1):349-54
pubmed: 21840004
Arch Neurol. 2012 Dec;69(12):1639-40
pubmed: 22986451
JAMA Surg. 2015 Dec;150(12):1134-40
pubmed: 26352694
Neurology. 2009 May 5;72(18):1570-5
pubmed: 19414723
Psychiatr Genet. 2007 Oct;17(5):261-6
pubmed: 17728664
Int J Geriatr Psychiatry. 2007 Jul;22(7):688-94
pubmed: 17203511
J Am Med Dir Assoc. 2017 Dec 1;18(12):1010-1018.e1
pubmed: 28927945
J Am Geriatr Soc. 2005 Feb;53(2):312-8
pubmed: 15673358
J Alzheimers Dis. 2018;61(1):347-358
pubmed: 29171992
Biol Psychiatry. 2017 Jan 15;81(2):145-153
pubmed: 27160518
Anesthesiology. 2007 Sep;107(3):406-11
pubmed: 17721242
J Anesth. 2012 Feb 1;:
pubmed: 22302107
Arch Med Sci. 2016 Dec 1;12(6):1247-1255
pubmed: 27904515
Am J Alzheimers Dis Other Demen. 2007 Jun-Jul;22(3):223-8
pubmed: 17606532
Lancet. 2014 Mar 8;383(9920):911-22
pubmed: 23992774
N Engl J Med. 2012 Jul 5;367(1):30-9
pubmed: 22762316
Alzheimers Res Ther. 2017 Apr 27;9(1):29
pubmed: 28446202
Ann Surg. 2009 Jan;249(1):173-8
pubmed: 19106695
Biodemography Soc Biol. 2011;57(1):33-52
pubmed: 21845926
J Gen Intern Med. 1998 Mar;13(3):204-12
pubmed: 9541379
Am J Geriatr Psychiatry. 2015 Oct;23(10):1029-1037
pubmed: 26238230
Am J Med. 2007 Sep;120(9):807-13
pubmed: 17765051
Neurobiol Aging. 2017 Nov;59:55-63
pubmed: 28846882

Auteurs

Sarinnapha M Vasunilashorn (SM)

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Long H Ngo (LH)

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Sharon K Inouye (SK)

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Marcus Institute for Aging Research, Boston, MA, USA.

Tamara G Fong (TG)

Harvard Medical School, Boston, MA, USA.
Marcus Institute for Aging Research, Boston, MA, USA.
Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Richard N Jones (RN)

Marcus Institute for Aging Research, Boston, MA, USA.
Brown University Warren Alpert Medical School, Providence, RI, USA.

Simon T Dillon (ST)

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Towia A Libermann (TA)

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Margaret O'Connor (M)

Harvard Medical School, Boston, MA, USA.
Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.

Steven E Arnold (SE)

Harvard Medical School, Boston, MA, USA.
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

Zhongcong Xie (Z)

Harvard Medical School, Boston, MA, USA.
Department of Anesthesiology, Massachusetts General Hospital, Boston, MA, USA.

Edward R Marcantonio (ER)

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Marcus Institute for Aging Research, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH